Application and challenges of stem cells in cardiovascular aging

• Published in: Regenerative therapy 2024-03, Vol.25, p.1-9
• Main Authors: Yuan, He-Ling, Chang, Le, Fan, Wei-Wen, Liu, Xin, Li, Qiang, Tian, Chuan, Zhao, Jing, Li, Zi-An, Pan, Xing-Hua, Zhu, Xiang-Qing
• Format: Article
• Language: English
• Subjects: Cardiovascular aging; Cardiovascular disease; Exocrine body; Stem cells; Treatment
• ISSN: 2352-3204; 2352-3204
• DOI: 10.1016/j.reth.2023.11.009

With the rapid development of society and the economy, population aging has become a common challenge faced by many countries in the world today. Structural and functional changes in the cardiovascular system can occur with age, increasing the incidence and severity of cardiovascular diseases in older adults. Due to the limited regenerative capacity of myocardial cells, myocardial infarction and its resulting heart failure and congenital heart disease have become the number one killer of human health. At present, the treatment of cardiovascular diseases includes drug therapy and nondrug therapy. Nondrug therapy mainly includes minimally invasive interventional therapy, surgical diagnosis and treatment, and cell therapy. Long-term drug treatment may cause headache due to vasodilation, lower blood pressure, digestive system dysfunction and other side effects. Surgical treatment is traumatic, difficult to treat, and expensive. In recent years, stem cell therapy has exhibited broad application prospects in basic and clinical research on cardiovascular disease because of its plasticity, self-renewal and multidirectional differentiation potential. Therefore, this paper looks at stem cell therapy for diseases, reviews recent advances in the mechanism and clinical transformation of cardiovascular aging and related diseases in China, and briefly discusses the development trend and future prospects of cardiovascular aging research.